Sana Biotechnology, Inc. · NASDAQ:SANA
Robert Nelsen reported a 17.30% stake in Sana Biotechnology, Inc. (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
Robert Nelsen reported a 17.30% stake in Sana Biotechnology, Inc., 46,093,125 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 17.30%
- Shares
- 46,093,125
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 15 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| ARCH Venture Fund IX, L.P. | 17.20% | 45,860,681 |
| ARCH Venture Fund IX Overage, L.P. | 17.20% | 45,860,681 |
| ARCH Venture Fund X, L.P. | 17.20% | 45,860,681 |
| ARCH Venture Fund X Overage, L.P. | 17.20% | 45,860,681 |
| ARCH Venture Partners IX, L.P. | 17.20% | 45,860,681 |
| ARCH Venture Partners IX Overage, L.P. | 17.20% | 45,860,681 |
| ARCH Venture Partners X Overage, L.P. | 17.20% | 45,860,681 |
| ARCH Venture Partners X, L.P. | 17.20% | 45,860,681 |
| ARCH Venture Partners IX, LLC | 17.20% | 45,860,681 |
| ARCH Venture Partners X, LLC | 17.20% | 45,860,681 |
| Keith Crandell | 17.20% | 45,860,681 |
| Clinton Bybee | 17.20% | 45,860,681 |
| Robert Nelsen | 17.30% | 46,093,125 |
| Steven Gillis | 17.20% | 45,860,681 |
| Kristina Burow | 17.20% | 45,860,681 |
Source
Related
- Sana Biotechnology, Inc.
- Robert Nelsen
- Sana Biotechnology, Inc. shareholders
- Schedule 13G/A · Robert Nelsen · Aug 14, 2026
- Form 4 · Bishop Hans Edgar · Oct 6, 2026
- Form 4 · Patel Dhavalkumar Dhirajlal · Aug 27, 2026
- Form 4 · Bishop Hans Edgar · Jul 7, 2026
- Schedule 13G · Ra Capital Management, L.P. · May 21, 2026
- Form 4 · Bishop Hans Edgar · Apr 8, 2026